Background illustration for clinical trials search

Paid Clinical Trials Providence

Discover 489 paid clinical trials in Providence, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer, Testicular Cancer,
Location: Providence RI, Boston MA, New York NY, Durham NC,
Sponsor: Context Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06515613

Phase 1, Recruiting

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

for
Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor,
Location: Providence RI, New York NY, Charlotte NC,
Sponsor: Aadi Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05997017

Phase 2, Recruiting

Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Providence RI, Worcester MA, New York NY,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT06388018

Phase 2, Recruiting

Training for Urinary Leakage Improvement After Pregnancy

for
Urinary Incontinence, Delivery Complication
Location: Providence RI, Philadelphia PA, Durham NC, Chicago IL,
Sponsor: NICHD Pelvic Floor Disorders Network

Sex: Female

Age: 18+

Code: NCT06411158

Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Providence RI, Boston MA, Doylestown PA, Camden NJ,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Salivary Profiling in Infants Treated for Suspected Sepsis: The SPITSS Study

for
Infection; Newborn
Location: Providence RI, Boston MA, Gainesville FL
Sponsor: Tufts Medical Center

Sex: All

Age: 0+

Code: NCT05490212

Recruiting

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

for
Iron Deficiency Anemia, Pregnancy
Location: Providence RI, Ann Arbor MI, St Louis MO, Birmingham AL,
Sponsor: Women and Infants Hospital of Rhode Island

Sex: Female

Age: 18 - 45

Code: NCT05462704

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Providence RI, New Haven CT, Scarborough ME, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase 3, Recruiting

Oral vs Intravesical Analgesia for Office Bladder Botox Injections

for
Overactive Bladder Syndrome, Urge Incontinence,
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: Female

Age: 18 - 70+

Code: NCT03755089

Recruiting

Generalizing TESTPILOT to New Single Family Room NICUs

for
Patient Safety, Organizational Change
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: All

Age: 0+

Code: NCT02574104

Recruiting

Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change

for
Perinatal Mental Health
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: Female

Age: 18+

Code: NCT06849869

Recruiting

The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection

for
Postoperative Complications
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: Female

Age: 18+

Code: NCT05625373

Phase 2, Phase 3, Recruiting

Bringing Medicines for HIV Prevention to a Family Planning Clinic

for
HIV, PrEP
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: All

Age: 16+

Code: NCT06930508

Recruiting

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Providence RI, Stamford CT, West Islip NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07391774

Phase 3, Recruiting

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for
Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer,
Location: Providence RI, Teaneck NJ, Syracuse NY, Fairfax VA,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07024784

Phase 2, Recruiting

Rhode Island Community-based Maternal Support Services

for
Perinatal Outcomes, Social Determinants of Health (SDOH),
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: Female

Age: 0+

Code: NCT07446374

Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

for
Ovarian Neoplasms, Ovarian Cancer
Location: Providence RI, Scarborough ME, Albany NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07318558

Phase 3, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Providence RI, Farmington CT, Scarborough ME,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase 3, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Providence RI, Mineola NY, New York NY, Willow Grove PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase 3, Recruiting

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Providence RI, New Haven CT, Danbury CT, Norwalk CT,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase 2, Recruiting